Products for Research Use Only

Bone Morphogenetic Protein 4, BMP4

CAT: 0013-GTR19145288-01Size: 10 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19145288-01Size:10 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Recombinant mature human BMP4 is produced in HEK293 cells using stable mammalian expression. This tag-free, liquid-formulated, research-grade protein is purified through a gentle mixed-mode chromatography process designed to preserve its native structure and biological activity. It is suitable for stem cell differentiation, developmental biology, organoid workflows, lineage specification, and media development applications. (Tested applications: Functional studies, ImmunoAssay, Western Blot.)
Product Name Alternative
Bone Morphogenetic Protein 4, BMP4, BMP-4, BMP2B, BMP-2B, ZYME, DVR4
UniProt
P12644
Expression Region
293-408 aa
Tag
No tag
Origin
Human
Field of Research
Stem Cell & Developmental Biology; Musculoskeletal & Connective Tissue Research
Purity
>95%
Form
Liquid (Sterile-filtered)
Molecular Weight
13 kDa
Storage Conditions
4°C for short-term and -70°/80°C long-term
Notes
For research use only.
Applications Notes
Biologically active and independently validated against human BMP4 from R&D Systems in two differentiation models. 1. In a cardiac differentiation model, Daresbury BMP4 supported beating embryoid body formation and NKX2.5-GFP expression at 11 ng/mL, compared with 25 ng/mL for the commercial reference under the reported conditions. 2. In day-5 trophoblast differentiation of MAN13 hESCs at 10 ng/mL, this product induced CDX2, GATA3, KRT7, and TFAP2A expression by 1540-, 2350-, 7.69-, and 4542-fold, respectively, relative to the untreated control (= 1) . These responses corresponded to approximately 90%, 122%, 88%, and 88% of the R&D Systems reference response, respectively.
Tested Applications
FA, WB
Preservative
20mM histidine pH 5.5, 0.2M NaCl, 0.6M arginine
AA Sequence
SPKHHSQRARKKNKNCRRHSLYVDFSDVGWNDWIVAPPGYQAFYCHGDCPFPLADHLNSTNHAIVQTLVNSVNSSIPKACCVPTELSAISMLYLDEYDKVVLKNYQEMVVEGCGCR